JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has submitted a routine compliance certificate to the stock exchange for the October–December 2025 quarter. The certificate, issued by the company's Registrar and Share Transfer Agent, Datamatics Business Solutions, confirms that all share certificates received for dematerialization during the quarter were properly cancelled and the depository's name was recorded as the registered owner within the 15-day deadline set by SEBI. This is a standard quarterly filing required under SEBI's depository regulations and reflects normal back-office activity. There is no change to the company's share capital, no corporate action, and no impact on shareholders.
This is a procedural compliance filing with no bearing on the company's financials, business, or stock price. Shareholders do not need to take any action.